RIN1 and head and neck squamous cell carcinoma: Among a larger collection of “next generation” drugs available for research purposes (including also SAHM1, FLI-06 and Yhhu-3792), we focused on a potential Notch signalling activator, RIN-1, and putative inhibitor, CB-103 which were tested against HNSCC cells.